These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7873326)

  • 1. Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.
    Di Lenarda A; Secoli G; Perkan A; Gregori D; Lardieri G; Pinamonti B; Sinagra G; Zecchin M; Camerini F
    Br Heart J; 1994 Dec; 72(6 Suppl):S46-51. PubMed ID: 7873326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.
    Di Lenarda A; De Maria R; Gavazzi A; Gregori D; Parolini M; Sinagra G; Salvatore L; Longaro F; Bernobich E; Camerini F
    Heart; 1998 Apr; 79(4):337-44. PubMed ID: 9616339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival of idiopathic dilated cardiomyopathy in the 1990s.
    Azuma A; Matsuo A; Nakamura T; Kawasaki T; Yamamoto K; Hyogo M; Hirata A; Hirasaki S; Shima T; Sugihara H; Kunishige H; Kuribayashi T; Nakagawa M
    Jpn Circ J; 1999 May; 63(5):333-8. PubMed ID: 10943610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years.
    Matsumura Y; Takata J; Kitaoka H; Kubo T; Baba Y; Hoshikawa E; Hamada T; Okawa M; Hitomi N; Sato K; Yamasaki N; Yabe T; Furuno T; Nishinaga M; Doi Y
    Circ J; 2006 Apr; 70(4):376-83. PubMed ID: 16565551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvement of prognosis in idiopathic dilated cardiomyopathy: role of early diagnosis and optimized medical treatment. Study Group on Heart Muscle Diseases].
    Di Lenarda A; Hlede S; Sabbadini G; Davanzo M; Di Chiara C; Scherl G; Zanchi C; Sinagra G
    G Ital Cardiol; 1999 Dec; 29(12):1452-62. PubMed ID: 10687108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The epidemiology of heart failure in Japan].
    Okamoto H; Kitabatake A
    Nihon Rinsho; 2003 May; 61(5):709-14. PubMed ID: 12754992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care.
    Tsuda E; Yamada O; Kitano M
    J Cardiol; 2019 Aug; 74(2):189-194. PubMed ID: 30876708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G
    Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
    Singh TP; Almond C
    J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
    [No Abstract]   [Full Text] [Related]  

  • 20. Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology.
    Miranda JO; Costa L; Rodrigues E; Teles EL; Baptista MJ; Areias JC
    Cardiol Young; 2015 Feb; 25(2):333-7. PubMed ID: 24423967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.